Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET
Company Participants
Robert Borchert - Investor Relations
Shawn Morris - Chief Executive Officer
Parth Mehrotra - President and Chief Operating Officer
David Mountcastle - Chief Financial Officer
Conference Call Participants
Joshua Raskin - Nephron Research
Jailendra Singh - Truist
Richard Close - Canaccord Genuity
Lisa Gill - JPMorgan
Ryan Daniels - William Blair
Sandy Draper - Guggenheim
Whit Mayo - SVB
David Larsen - BTIG
Brian Tanquilut - Jefferies
Adam Ron - Bank of America
Jessica Tassan - Piper Sandler
Operator
Good day and thank you for standing by. Welcome to the Privia Health Q3 2022 Conference Call. [Operator Instructions] Please be reminded that this conference call is being recorded. I would now like to turn the call over today to Robert Borchert, SVP of Investor and Corporate Communications. Please go ahead, sir.
Robert Borchert
Thank you, Lisa and good morning everyone. Joining me today are Shawn Morris, our Chief Executive Officer; Parth Mehrotra, President and Chief Operating Officer; and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed from the Invest Relations section of priviahealth.com.
Today’s press release highlighting our financial and operating performance and the slide presentation accompanying our formal remarks are posted on the Investor Relations pages of priviahealth.com. Following our prepared comments, we will open the line for questions. We ask that you please limit yourself to one question and one follow-up so we can get through the full queue in a timely fashion.
The financial results reported today and in the press release are preliminary and are not final until our Form 10-Q for the quarter ended September 30, 2022 is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature based on our current expectations and our view of our business as of November 10, 2022. Such statements, including those related to our future financial and operating performance and future plans and objectives, are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered in conjunction with the cautionary statements in today’s press release and the risk factors described in our company’s most recent SEC filings.
Finally, we may refer to certain non-GAAP financial measures on the call, and reconciliations of these measures to comparable GAAP measures are included in our press release and the accompanying slide presentation posted on our website.